|Last Price$77.61||Day Change (%)-1.13%|
|Open Price$78.48||Day Change ($)-0.89|
|Day Range77.58–78.48||52-Week Range57.80–79.50|
As of Fri 4/24/2015 5:28:00 PM | USD
Ladies and gentlemen, thank you for standing by, and welcome to the Medtronic Fourth Quarter Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. Thank you.
DreaMed Diabetes and Medtronic Enter Strategic Collaboration
Study of Upper Airway Stimulation (UAS) Therapy for Sleep Apnea Named a Top Ten Outstanding Research Paper
The device maker's planned acquisition of Covidien will make it a force to be reckoned with.
The firm is on track to meet our full-year estimates, and our $60 per share fair value estimate and wide moat rating are intact.
Research and Markets: North American Nerve Repair & Regeneration Market by Type, by Procedure - Forecast to 2019
Research and Markets: MedIntelliBase Lower Limb Critical Limb Ischemia Therapeutics MarketTracksTM ("CLI-LL MarketTracks")